BONIUK MILTON

Average Profitability
<0.0001%
Insider Buys Quantity
35
Insider Buys Sum
$5.49M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of BONIUK MILTON

The largest purchase of all time was on 2013-09-12 and amounted to 857142 shares of NanoViricides, Inc. for $3M.

Biography of BONIUK MILTON

No biography is available at this moment.

2015-11-11PurchaseNanoViricides, Inc.
NNVC
director
25,000
0.0431%
$1.20$30,000+33.88%
2015-10-22PurchaseNanoViricides, Inc.
NNVC
director
14,640
0.0254%
$1.30$19,032+24.62%
2015-10-21PurchaseNanoViricides, Inc.
NNVC
director
5,202
0.009%
$1.30$6,763+24.62%
2015-10-19PurchaseNanoViricides, Inc.
NNVC
director
2,958
0.0051%
$1.30$3,845+22.73%
2015-10-15PurchaseNanoViricides, Inc.
NNVC
director
2,200
0.0037%
$1.30$2,860+20%
2015-09-11PurchaseNanoViricides, Inc.
NNVC
director
50,000
0.0873%
$1.02$51,000+53.92%
2015-08-26PurchaseNanoViricides, Inc.
NNVC
director
50,000
0.0921%
$1.05$52,500+55.65%
2015-08-21PurchaseNanoViricides, Inc.
NNVC
director
29,853
0.053%
$1.25$37,316+26.02%
2015-08-20PurchaseNanoViricides, Inc.
NNVC
director
2,662
0.0046%
$1.25$3,328+24%
2015-08-19PurchaseNanoViricides, Inc.
NNVC
director
300
0.0005%
$1.25$375+20.16%
2015-08-18PurchaseNanoViricides, Inc.
NNVC
director
2,547
0.0043%
$1.25$3,184+20.16%
2015-08-17PurchaseNanoViricides, Inc.
NNVC
director
5,244
0.0092%
$1.25$6,555+24%
2015-08-14PurchaseNanoViricides, Inc.
NNVC
director
8,594
0.0148%
$1.25$10,743+20.47%
2015-08-13PurchaseNanoViricides, Inc.
NNVC
director
800
0.0013%
$1.25$1,000+14.18%
2015-07-08PurchaseNanoViricides, Inc.
NNVC
director
50,000
0.092%
$1.58$79,000-6%
2015-06-22PurchaseNanoViricides, Inc.
NNVC
director
43,472
0.074%
$1.90$82,597-27.69%
2015-06-19PurchaseNanoViricides, Inc.
NNVC
director
6,528
0.0113%
$1.90$12,403-27.08%
2015-06-16PurchaseNanoViricides, Inc.
NNVC
director
42,247
0.0738%
$1.99$84,072-29.15%
2015-06-15PurchaseNanoViricides, Inc.
NNVC
director
7,753
0.0135%
$2.00$15,506-29.5%
2015-05-20PurchaseNanoViricides, Inc.
NNVC
director
25,000
0.0431%
$1.60$40,000-12.96%
Total: 35
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.